APO 25 (Zonisamide 25 mg)

Pill imprint APO 25 has been identified as Zonisamide 25 mg.

Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO 25

Zonisamide 25 mg APO 25
Zonisamide 25 mg APO 25
Zonisamide
Imprint:
APO
25
Strength:
25 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2545
Inactive Ingredients:
silicon dioxide
microcrystalline cellulose
stearic acid
magnesium silicate
ferrosoferric oxide
gelatin
titanium dioxide
ammonia
butyl alcohol
alcohol
isopropyl alcohol
potassium hydroxide
propylene glycol
shellac

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)